Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Aura Biosciences, Inc. (AURA) had Earnings per Share (EPS) (Basic) of $-0.34 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-25.56M |
|
-- |
|
-- |
|
$27.24M |
|
$-27.24M |
|
$1.69M |
|
$-25.54M |
|
$-25.54M |
|
$-25.56M |
|
$-25.56M |
|
$-25.56M |
|
$-25.56M |
|
$-27.24M |
|
$-26.96M |
|
60.34M |
|
60.34M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.34 |
$-0.34 |
|
| Balance Sheet Financials | |
$149.74M |
|
$2.62M |
|
$19.69M |
|
$169.43M |
|
$18.38M |
|
-- |
|
$14.13M |
|
$32.52M |
|
$136.91M |
|
$136.91M |
|
$136.91M |
|
63.59M |
|
| Cash Flow Statement Financials | |
$-84.74M |
|
$35.59M |
|
$77.16M |
|
$32.46M |
|
$60.28M |
|
$27.82M |
|
$14.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-85.19M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-18.67% |
|
-18.67% |
|
-15.09% |
|
-18.67% |
|
$2.15 |
|
$-1.41 |
|
$-1.40 |
|